The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.70 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual General Meeting Invitation

28 Mar 2019 07:48

RNS Number : 2986U
EFG-Hermes Holdings SAE
28 March 2019
 

TRANSLATION FROM ARABIC

Invitation to

The Annual General Meeting

EFG Hermes Holding S.A.E.

 

The Chairperson of the Board of Directors of EFG Hermes Holding S.A.E., an Egyptian joint stock company with authorized capital of EGP 6 billion (Only EGP Six billion) and issued and paid-in capital of EGP 3,843,091,115 (Only three billion eight hundred forty three million ninety one thousand one hundred fifteen Egyptian Pounds), registered under no. 12665 at 6th October Commercial Registry of Giza, kindly invites its shareholders to attend the Company's Annual General Meeting at 2:30 PM on 21st April 2019 at "Joy Club" Ballroom of the Steigenberger Cairo Pyramids Hotel (previously Mövenpick), Giza, in order to consider the following items on the agenda:

1. Approve the Board of Directors report on the Company's activities for the fiscal year ended 31/12/2018;

2. Approve the auditor's report on the financial statements for the fiscal year ended 31/12/2018;

3. Ratify the financial statements for the fiscal year ended 31/12/2018;

4. Approve the corporate governance report for the fiscal year ended 31/12/2018;

5. Approve the proposed dividend distribution for the fiscal year ended 31/12/2018;

6. Discharge the Chairperson and Members of the Board from all liabilities with regard to the activities during the fiscal year 2018, and ratify the changes in the Board which occurred during the fiscal year 2018

7. Approve the Board of Directors' attendance and travel allowances for the fiscal year 2019;

8. Approve the re-appointment of the Company's auditors for the fiscal year 2019 and delegate the Board of Directors for determining their fees;

9. Ratify all donations during 2018 and authorize the Board of Directors to approve donations during the fiscal year 2019.

 

 

In this respect, please note the following:

First: Each shareholder has the right to attend the General Meeting either in person, or by delegating another shareholder who is not a Board member. Delegation, to be valid, must be stated in a written proxy, and no shareholder, except for juridical persons, shall be entitled to represent, by proxy, a number of votes exceeding 10% of the total shares of the Company's capital and not to exceed 20% of the shares represented in the meeting.

 

Second: Shareholders who wish to attend the General Meeting must submit a statement of account on their shares deposited with a custodian, confirming that the shares deposited have been temporarily blocked for the purpose of attending the meeting.

 

Third: Any questions regarding the issues to be reviewed by the Ordinary General Meeting must be submitted in writing to the Company's management at the Head Office, either by registered mail or by hand delivery against receipt, at least three days prior to the date of the General Meeting. Discussion in the General Meeting shall be limited to the issues listed in the agenda.

 

Fourth: Resolutions of the Ordinary General Meeting shall be issued by absolute majority of the shares represented in the meeting.

 

Fifth: This meeting is considered valid with the representation of 25% of the Company's total outstanding shares. In the event of a lack of legal quorum, a second meeting will be convened on the next day at the same time and place and will be valid irrespective of the percentage of shares represented thereat.

 

Sixth: Attendance of the meeting is restricted to shareholders with no accompanying guests. We would like to request the shareholders to arrive half an hour before the designated meeting time to allow for registration of attendance upon submission of identification documents and proxies.

 

 

 

 

Mona Zulficar

Chairperson of the Board of Directors

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRCKFDQOBKKANB
Date   Source Headline
21st Oct 20133:45 pmRNSSecond Price Monitoring Extn
21st Oct 20133:40 pmRNSPrice Monitoring Extension
8th Oct 20137:00 amRNSCo-CEO of EFG Hermes Holding Steps Down
1st Oct 20138:52 amRNSStatement Appointment of Asset Management Head
30th Sep 20133:45 pmRNSSecond Price Monitoring Extn
30th Sep 20133:40 pmRNSPrice Monitoring Extension
12th Sep 20139:08 amRNSBonus Share Distribution
2nd Sep 20137:00 amRNS2nd Quarter Results
30th Jul 20139:17 amRNSStatement re Sale of Non-core Assets
25th Jul 201310:06 amRNSResult of second EGM
8th Jul 20139:18 amRNSNotice of EGM
8th Jul 20137:00 amRNSResult of AGM and EGM
17th Jun 20139:11 amRNSNotice of EGM
17th Jun 20139:08 amRNSNotice of AGM
4th Jun 20139:34 amRNSDirectorate Change
22nd May 20139:04 amRNS1st Quarter Results
14th May 20139:45 amRNSResult of Board Meeting
2nd May 20138:39 amRNSExpiration of QInvest JV Agreement
2nd May 20138:39 amRNSStrategy following Expiration of QInvest agreement
16th Apr 201312:08 pmRNSStatement re QInvest Deal
3rd Apr 20139:08 amRNSFY2012 Results
2nd Apr 20133:45 pmRNSSecond Price Monitoring Extn
2nd Apr 20133:40 pmRNSPrice Monitoring Extension
21st Mar 20137:28 amRNSCourt declines freeze of CEOs assets
18th Mar 20138:46 amRNSFreezing of CEOs Assets
19th Nov 20128:32 amRNS3rd Quarter Results
9th Nov 20123:45 pmRNSSecond Price Monitoring Extn
9th Nov 20123:40 pmRNSPrice Monitoring Extension
15th Oct 20128:35 amRNSStatement re EFSA certifies EGM
17th Sep 20127:00 amRNSEGM Statement
31st Aug 20127:00 amRNSNotice of EGM
30th Aug 20123:25 pmRNSStatement re Board of Directors Resolutions
15th Aug 201210:03 amRNSHalf Yearly Report
26th Jul 20129:45 amRNSEGM Statement
12th Jun 201211:45 amRNSClarification
8th Jun 20123:45 pmRNSSecond Price Monitoring Extn
8th Jun 20123:40 pmRNSPrice Monitoring Extension
6th Jun 20127:00 amRNSStatement re Legal Action
6th Jun 20127:00 amRNS1st Quarter Results
6th Jun 20127:00 amRNSResults of AGM and EGM
31st May 201211:17 amRNSStatement
31st May 20128:58 amRNSStatement from EFG Hermes
31st May 20128:53 amRNSStatement re. Press Comment
30th May 201211:09 amRNSStatement re BoD Resolutions
16th May 20124:09 pmRNSAGM & EGM Invitation - Replacement
16th May 20129:42 amRNSAGM & EGM Invitation
10th May 20123:45 pmRNSSecond Price Monitoring Extn
10th May 20123:40 pmRNSPrice Monitoring Extension
8th May 20127:00 amRNSRe Agreement
26th Apr 20129:23 amRNSStatement re. Press Comment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.